Effect of transforming growth factor-β1 on the cell growth and Epstein-Barr virus reactivation in EBV-infected epithelial cell lines

被引:34
作者
Fukuda, M
Ikuta, K
Yanagihara, K
Tajima, M
Kuratsune, H
Kurata, T
Sairenji, T [1 ]
机构
[1] Tottori Univ, Fac Med, Sch Life Sci, Dept Biosignaling, Yonago, Tottori 6838503, Japan
[2] Natl Canc Ctr, Res Inst, Cent Anim Lab, Tokyo 1040045, Japan
[3] Teikyo Univ, Sch Med, Cent Clin Lab, Tokyo 1738606, Japan
[4] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Osaka 5658640, Japan
[5] Natl Inst Infect Dis, Dept Pathol, Tokyo 1628640, Japan
基金
日本科学技术振兴机构;
关键词
D O I
10.1006/viro.2001.1071
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Transforming growth factor (TGF)-beta1 is a multifunctional cytokine that plays important roles in regulating cell growth and differentiation in many biological systems. In this study, we found that gastric tissue-derived Epstein-Barr virus (EBV)-infected epithelia[ cell lines GT38 and GT39 had resistance to TGF-beta1-mediated growth inhibition and apoptosis compared to a TGF-beta1 -susceptible gastric carcinoma cell line HSC-39. However, TGF-beta1 partially Induced EBV reactivation In GT38 and GT39 cells, as shown by the Induction of EBV immediate-early BZLF1 RNA and its protein product ZEBRA and early antigen-D. The expressions of TGF-beta receptor I and II were detected in GT38 and GT39 cells by Northern and Western blot analyses. Both cell lines spontaneously produced the TGF-beta1, which was sufficient for inhibiting cell growth of HSC-39 cells. Taken together, these data suggest that TGF-beta1 may be a key factor for EBV reactivation and selective growth of EBV-infected epithelial cells in vivo. (C) 2001 Academic Press.
引用
收藏
页码:109 / 118
页数:10
相关论文
共 43 条
  • [31] SHIBATA D, 1992, AM J PATHOL, V140, P769
  • [32] TRANSFORMING GROWTH-FACTOR-BETA - RECENT PROGRESS AND NEW CHALLENGES
    SPORN, MB
    ROBERTS, AB
    [J]. JOURNAL OF CELL BIOLOGY, 1992, 119 (05) : 1017 - 1021
  • [33] Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: Unique viral latency in the tumour cells
    Sugiura, M
    Imai, S
    Tokunaga, M
    Koizumi, S
    Uchizawa, M
    Okamoto, K
    Osato, T
    [J]. BRITISH JOURNAL OF CANCER, 1996, 74 (04) : 625 - 631
  • [34] SUN LZ, 1994, J BIOL CHEM, V269, P26449
  • [35] TAHARA E, 1990, J CANCER RES CLIN, V119, P265
  • [36] Establishment of Epstein-Barr virus-positive human gastric epithelial cell lines
    Tajima, M
    Komuro, M
    Okinaga, K
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 1998, 89 (03): : 262 - 268
  • [37] Productive infection of Epstein-Barr virus (EBV) in EBV-genome-positive epithelial cell lines (GT38 and GT39) derived from gastric tissues
    Takasaka, N
    Tajima, M
    Okinaga, K
    Satoh, Y
    Hoshikawa, Y
    Katsumoto, T
    Kurata, T
    Sairenji, T
    [J]. VIROLOGY, 1998, 247 (02) : 152 - 159
  • [38] DEMONSTRATION THAT MUTATION OF THE TYPE-II TRANSFORMING GROWTH-FACTOR-BETA RECEPTOR INACTIVATES ITS TUMOR-SUPPRESSOR ACTIVITY IN REPLICATION ERROR-POSITIVE COLON-CARCINOMA CELLS
    WANG, J
    SUN, LZ
    MYEROFF, L
    WANG, XF
    GENTRY, LE
    YAN, JH
    LIANG, JR
    ZBOROWSKA, E
    MARKOWITZ, S
    WILLSON, JKV
    BRATTAIN, MG
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (37) : 22044 - 22049
  • [39] EPSTEIN-BARR VIRUS INDUCTION BY A SERUM FACTOR .4. UBIQUITOUS OCCURRENCE OF THE FACTOR WITHIN VERTEBRATES AND ITS INTERACTION WITH DEFINED LYMPHOID-CELL LINES
    WITTMANN, P
    HOFLER, P
    BAUER, G
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1982, 30 (04) : 503 - 510
  • [40] Yamamoto M, 1996, CANCER-AM CANCER SOC, V77, P1628, DOI 10.1002/(SICI)1097-0142(19960415)77:8+<1628::AID-CNCR7>3.0.CO